Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19
Clinical trial NCT04780035 · COMPLETED
Trial details
- NCT number
- NCT04780035
- Sponsor
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2021-08-31
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.